Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

53.84 -2.47 (-4.39%)
Streaming Delayed Price Updated: 10:29 AM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,313,773
Open 56.39
Bid (Size) 53.83 (2)
Ask (Size) 53.84 (5)
Prev. Close 56.31
Today's Range 53.81 - 56.74
52wk Range 54.00 - 83.25
Shares Outstanding 1,319,574,744
Dividend Yield 4.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Expert Outlook: CVS Health Through The Eyes Of 11 Analysts
Via Benzinga
CVS Is Sick
One would figure the nation’s biggest pharmacy would be a safe, conservative investment. Nope. CVS​​​​​​​ has lost about HALF its value in just two years. 
Via Talk Markets

Performance

YTD
-33.41%
-33.41%
1 Month
-32.33%
-32.33%
3 Month
-27.61%
-27.61%
6 Month
-21.66%
-21.66%
1 Year
-26.00%
-26.00%

More News

Read More
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Schall Law
Via GlobeNewswire
CVS Health (CVS) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Moody’s, Booking, DraftKings, Amgen Stocks In Focus Ahead Of Earnings
Via Talk Markets
Topics Economy Stocks
Exposures Interest Rates US Equities
Why CVS Health Stock Plunged Today
Via The Motley Fool
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Is This Beaten-Down Dividend Stock a Buy?
Via The Motley Fool
CVS Shares Dump On Earnings Miss, Outlook Slashed On Rising Medical Costs
Via Talk Markets
Topics Earnings
Exposures Financial
CVS Stock Earnings: CVS Health Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Rising Cost For Health Insurers Bites CVS Health's Q1 Profit, Stock Tanks
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CVS Health Dives To 3-Year Low On Medicare Cost Surge
Via Investor's Business Daily
Humana Leaves Shareholders in Limbo on 2025 EPS Guidance
Via MarketBeat
Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
Via Benzinga
Topics Economy
Exposures Interest Rates
CVS Stock is Nearing a 52-Week Low, Better Buy Than Walgreens?
Via MarketBeat
Walmart Pulls Plug On Health Centers, Telehealth; Respite For TDOC?
Via Investor's Business Daily
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
Via Investor's Business Daily
DoorDash: 5 Compelling Reasons to Buy the Dip
Via MarketBeat
Topics Death
Exposures Death
3 Value Stocks to Buy on the Dip: April 2024
Via InvestorPlace
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
Via Benzinga
5 High-Yielding Oversold Stocks with Bullish Ratings
Via MarketBeat
Topics Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.